# Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2018

- Company: [Fresenius Medical Care AG](/companies/fms.md) (CIK 1333141)
- Form: 20-F
- Filed: 2019-02-20
- Accepted by EDGAR: Feb 20, 2019, 14:02 ET
- Period: 2018-12-31
- Accession: 0001047469-19-000562
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1333141/000104746919000562/a2237687z20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1333141/000104746919000562/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2018-01-01 to 2018-12-31 | EUR 16.55bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2018-01-01 to 2018-12-31 | EUR 11.39bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2018-01-01 to 2018-12-31 | EUR 5.15bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2018-01-01 to 2018-12-31 | EUR 3.04bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2018-01-01 to 2018-12-31 | EUR 511.1m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | EUR 1.98bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2018-01-01 to 2018-12-31 | EUR 6.45 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2018-01-01 to 2018-12-31 | EUR 6.47 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | EUR 2.06bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2018-01-01 to 2018-12-31 | −EUR 1.06bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2018-12-31 | EUR 2.15bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2018-12-31 | EUR 7.85bn | ifrs-full:CurrentAssets |
| Total assets | at 2018-12-31 | EUR 26.24bn | ifrs-full:Assets |
| Current liabilities | at 2018-12-31 | EUR 6.27bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2018-12-31 | EUR 13.34bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2018-12-31 | EUR 11.76bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2018-12-31 | 306,878,701 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1333141/000104746919000562/a2237687z20-f.htm

Filed Feb 20, 2019.
Source: SEC EDGAR, the filing index for accession 0001047469-19-000562. Last ingested by Listed: Nov 3, 2026, 10:24 ET. No prices; not investment advice.